nCounter® Human Organ Transplant Panel

Are you looking to develop signatures pre- and post-organ transplant to help determine risk of rejection? Then the nCounter Human Organ Transplant Panel is the research tool for you.

Helping Your Research

Panel Development

The Human Organ Transplant Panel was created through a collaboration between NanoString and the Banff Foundation for Allograft Pathology, a global consortium of researchers from multiple prestigious institutes, including researchers from the University of AlbertaErasmus Medical Center RotterdamImperial College LondonMassachusetts General HospitalUniversity of Oxford, and the Paris Transplant Group. The consortium aims to improve organ transplant outcomes through advanced molecular characterization of the in-situ response in the allograft and to make available a transformational new approach for research that can be used to accelerate the identification of new biomarkers of rejection, uncover the mechanisms behind tissue damage, and monitor toxicities brought on by immunosuppressive drugs and infections.

Banff 2019 Meeting Report

Read the Banff 2019 Meeting Report  to learn more about how the content for the Human Organ Transplant panel was created and how the Banff Molecular Diagnostics Working Group (MDWG) plans to maximize data collected using the panel through the formation of a consortium and access to a shared database.

nCounter Human Organ Transplant Panel

How it Works

You can comprehensively profile 770 genes across 37 pathways to identify biomarkers for rejection, uncover the mechanisms of tissue damage, and study toxicities brought on by immunosuppressive drugs.

01:

Study the immune response to transplanted tissue

02:

Discover biomarkers for organ rejection and tissue damage for kidney, heart, liver, and lung

03:

Evaluate immunosuppressive drug pathways

04:

Understand mechanisms behind drug-induced toxicity

05:

Identify BK Polyomavirus, Cytomegalovirus, and Epstein-Barr virus

06:

Quantify the relative abundance of 14 different immune cells

Panel Selection Tool

Find the gene expression panel for your research with Panel Pro

Find Your Panel

Product Information

Functional Annotations
Viral Identification
NHP Compatibility
Product Specifications
Catalog Information
Functional Annotations
Viral Identification

Solid organ and hematopoietic transplant recipients are at increased risk for developing complications from opportunistic viral infections and may even inherit a viral infection from the donor. Knowing if a viral infection is present can be essential to understanding both the immune response and the potential impact of immunosuppressive treatments. Included in the Human Organ Transplant panel are probes specific for the detection of BK Polyomavirus, Cytomegalovirus (CMV) and Epstein-Barr virus (EBV).

NHP Compatibility

Probes included in the Human Organ Transplant Panel have been confirmed to also have high homology to non-human primates providing a valuable tool for translational comparative studies using both human and non-human samples.

Product Specifications
Catalog Information

Related Resources

View All Resources
Product Bulletin Human Organ Transplant Panel – Product Bulletin
Manual/Instructions NanoU Training Videos
Blog Post Molecular Signatures of Antibody-Mediated Rejection and Graft Outcome After Kidney Transplantation. Q&A with Dr. Dela Golshayan, M.D., Ph.D.
Blog Post Solid Organ Transplantation and the Immunology of Rejection. Q&A with GeoMx® Digital Spatial Profiler Grant Winner Dr. Fadi Issa
Blog Post The bench side of organ transplant: Challenges and solutions
Blog Post Searching for New Biomarkers to Prevent Organ Transplant Rejection. Q&A with HOT Panel Grant Winner Dr. Evan Farkash

Publications

View All Publications

Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis

Ulcerative colitis (UC) is driven by immune and stromal subsets, culminating in epithelial injury. Vedolizumab (VDZ) is an anti-integrin antibody that is effective for treating UC.

In situ single-cell profiling sheds light on IFI27 localisation during SARS-CoV-2 infection

The utilization of single-cell resolved spatial transcriptomics to delineate immune responses during SARS-CoV-2 infection was able to identify M1 macrophages to have elevated expression of IFI27 in areas of infection.
The SARS-CoV-2 pandemic has affected over 600 million people to date, resulting in over 6.

Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures

Objectives: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) virus infection in pregnancy is associated with higher incidence of placental dysfunction, referred to by a few studies as a ‘preeclampsia‐like syndrome’. However, the mechanisms underpinning SARS‐CoV‐2‐induced placental malfunction are still unclear.

Request a Quote

Contact our helpful experts and we’ll be in touch soon.